logo
Select company
Select metric
1.13Cash Ratio
VS
Market
70
Sector
46
Industry
56
History
38
$ 27.32Close
$ 20.47 - $ 28.75 52-Week Range
Ticker Information

Ticker

BLFS

Company Name

BIOLIFE SOLUTIONS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

BIOLIFE SOLUTIONS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BLFS - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 31.9M1.13$ 28.31M
3/31/2025$ 66.94M2.41$ 27.72M
12/31/2024$ 95.39M2.91$ 32.73M
9/30/2024$ 24.16M0.75$ 32.17M
6/30/2024$ 22.05M0.72$ 30.82M
3/31/2024$ 29.73M0.77$ 38.66M
12/31/2023$ 35.44M0.84$ 42.18M
9/30/2023$ 19.27M0.45$ 42.62M
6/30/2023$ 21.43M0.54$ 39.59M
3/31/2023$ 19.14M0.4$ 47.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOLIFE SOLUTIONS INC's latest trailing twelve months (TTM) Cash Ratio stands at 13.03.
  • Over the past 5 years, BIOLIFE SOLUTIONS INC's average Cash Ratio has been 2.25.
  • The median Cash Ratio for BIOLIFE SOLUTIONS INC during this period was 0.98
  • BIOLIFE SOLUTIONS INC reached its highest Cash Ratio over the past 5 years at 13.03.
  • The lowest Cash Ratio recorded by BIOLIFE SOLUTIONS INC in the same timeframe 0.4

BIOLIFE SOLUTIONS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
SNDX : SYNDAX PHARMACEUTICALS INC 0.96IRMD : IRADIMED CORP 6.01NRIX : NURIX THERAPEUTICS INC 0.96URGN : UROGEN PHARMA LTD 1.98TBPH : THERAVANCE BIOPHARMA INC 5.18PDEX : PRO DEX INC 0.03SMTI : SANARA MEDTECH INC 1.14PLSE : PULSE BIOSCIENCES INC 11.85CBLL : CERIBELL INC 2.67ZVRA : ZEVRA THERAPEUTICS INC 1.65

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for BIOLIFE SOLUTIONS INC is calculated as follows: CashnEq [ $ 108.98M ] / LiabilitesC [ $ 8.36M ]
(=) Cash Ratio [ 13.03 ]

BLFS - Cash Ratio, Last 5 years

0.4

Minimum

Mar 31, 2023

13.03

Maximum

Sep 30, 2020

2.25

Average

0.98

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63